About FDA
FDA Broad Agency Announcement (BAA) or Program for Extramural Regulatory Science and Innovation (PERSI)
Description: PERSI encourages participation by science and technology based firms and educational institutions in meeting FDA goals for innovative ideas and approaches for regulatory science. PERSI-BAA identifies innovative and promising technologies for advanced development across the FDA which focuses on nine regulatory science research areas: (1) Modernize Toxicology to Enhance Safety; (2) Stimulate Innovation in Clinical Evaluation and Personalized Medicine to Improve Product Development and Patient Outcomes; (3) Support New Approaches to Improve Product Manufacturing and Quality; (4) Ensure FDA Readiness to Evaluate Innovative Emerging Technologies; (5) Harness Diverse Data Through Information Sciences to Improve Health Outcomes; (6) Enable a Prevention Focused Food Safety System; (7) Facilitate Development of Medical Countermeasures to Protect US and Global Health and Security; (8) Strengthen Social and Behavioral Science to Help Consumers and Professionals Make Informed Decisions; and (9) Strengthening the Global Product Safety Net. The BAA vehicle not only accelerates contract awards with flexible solicitation, but also reduces up-front planning and document reviews by creating unified advanced development solicitation. It provides flexibility to accommodate a range of contract awards (type, scope, number) in one vehicle which allows for market assessment of technologies. The BAA process starts with a quad chart/white paper review which will allow for a quick assessment of promising technologies from which to select full proposals. The second step includes establishing full review cycles of selected full proposals. After an extensive peer-review process, only a few proposals with the greatest importance to the FDA, are selected. PERSI-BAA is flexible and can be amended and modified anytime.
Accomplishment: The BAA program has sustained a consistent growth in the number of contract awards within FY14 and FY15. For example, FDA awarded 28 new projects in FY14 and 29 new projects in FY15. We completed 5 BAA projects in FY14 and 10 projects in FY15. Our FY16 awards are still in progress.
Briefing Status: ON TRACK
Prior Briefing Status: ON TRACK
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. Renew BAA |
5/23/2014 |
Completed | 5/23/2014 |
B. Complete FY14 3rd quarter full proposal reviews and monitor the progress of the executed awards |
6/30/2014 |
Completed | 8/28/2014 |
C. Complete FY14 4th quarter full proposal reviews and monitor the progress of the executed awards |
9/30/2014 |
Completed | 10/24/2014 |
D. Complete FY15 1st quarter full proposal reviews and monitor the progress of the executed awards |
12/31/2014 |
Completed | 1/28/2015 |
E. Complete FY15 2nd quarter full proposal reviews and monitor the progress of the executed awards |
3/31/2015 |
Completed | 3/31/2015 |
F. Complete FY15 3rd quarter full proposal reviews and monitor the progress of the executed awards |
6/30/2015 |
Completed | 6/30/2015 |
G. Complete FY15 4th quarter full proposal reviews and monitor the progress of the executed awards |
9/30/2015 |
Completed | 9/30/2015 |
H. Complete FY16 1st quarter full proposal reviews and monitor the progress of executed awards |
12/30/2015 |
Completed | 1/14/2016 |
I. Complete FY16 2nd quarter full proposal reviews and monitor the progress of executed awards |
3/30/2016 |
Completed | 5/30/2016 |
J. Complete FY16 3rd quarter full proposal reviews and monitor the progress of the executed awards |
6/30/2016 |
Completed | 7/1/2016 |
K. Complete FY16 4th quarter full proposal reviews and monitor the progress of the executed awards |
9/30/2016 |
Completed | 9/30/2016 |
L. Complete FY17 1st quarter full proposal reviews and monitor the progress of executed awards |
12/30/2016 |
Completed | 12/30/2016 |
M. Complete FY17 2nd quarter full proposal reviews and monitor the progress of executed awards |
3/30/2017 |
Completed | 3/21/2017 |
N. Complete FY17 3rd quarter full proposal reviews and monitor the progress of the executed awards |
6/30/2017 |
Completed | 6/30/2017 |
O. Complete FY17 4th quarter full proposal reviews and monitor the progress of the executed awards |
9/30/2017 |
Completed | 9/30/2017 |
Foot Notes
- New milestones will be added for FY 2018.
Key Projects Legend
Milestone Status | Definition |
---|---|
Not Yet Started | Work for specific milestone has not yet been started. |
Completed | Milestone and/or overall project is completed. |
On Track | Milestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status. |
On Hold | Milestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status. |
Delayed | Milestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status. |